|
US3887699A
(en)
|
1969-03-24 |
1975-06-03 |
Seymour Yolles |
Biodegradable polymeric article for dispensing drugs
|
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
GB1502774A
(en)
|
1974-06-25 |
1978-03-01 |
Nat Res Dev |
Immunological preparations
|
|
US4242501A
(en)
|
1979-08-08 |
1980-12-30 |
American Cyanamid Company |
Purification of pneumococcal capsular polysaccharides
|
|
US4270537A
(en)
|
1979-11-19 |
1981-06-02 |
Romaine Richard A |
Automatic hypodermic syringe
|
|
PH19942A
(en)
|
1980-11-18 |
1986-08-14 |
Sintex Inc |
Microencapsulation of water soluble polypeptides
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
US4436727A
(en)
|
1982-05-26 |
1984-03-13 |
Ribi Immunochem Research, Inc. |
Refined detoxified endotoxin product
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4987237A
(en)
|
1983-08-26 |
1991-01-22 |
Ribi Immunochem Research, Inc. |
Derivatives of monophosphoryl lipid A
|
|
DE3413608A1
(de)
|
1984-04-11 |
1985-10-24 |
Hoechst Ag, 6230 Frankfurt |
Implantierbare zubereitungen von regulatorischen peptiden mit gesteuerter freisetzung und verfahren zu ihrer herstellung
|
|
US4686102A
(en)
|
1984-04-12 |
1987-08-11 |
American Cyanamid Company |
Multivalent pneumococcal vaccine and preparation thereof
|
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US5916588A
(en)
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
CA1299099C
(en)
|
1986-03-06 |
1992-04-21 |
Paul Richard Wood |
In vitro assay for detecting cell-mediated immune responses
|
|
US4886499A
(en)
|
1986-12-18 |
1989-12-12 |
Hoffmann-La Roche Inc. |
Portable injection appliance
|
|
GB8704027D0
(en)
|
1987-02-20 |
1987-03-25 |
Owen Mumford Ltd |
Syringe needle combination
|
|
NZ224422A
(en)
|
1987-05-05 |
1990-11-27 |
Molecular Eng Ass |
Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US5339163A
(en)
|
1988-03-16 |
1994-08-16 |
Canon Kabushiki Kaisha |
Automatic exposure control device using plural image plane detection areas
|
|
FR2638359A1
(fr)
|
1988-11-03 |
1990-05-04 |
Tino Dalto |
Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
|
|
GB8906795D0
(en)
|
1989-03-23 |
1989-05-10 |
Carroll Noel |
Method of preparing vaccines
|
|
CA2017507C
(en)
|
1989-05-25 |
1996-11-12 |
Gary Van Nest |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
JPH0372423A
(ja)
|
1989-05-26 |
1991-03-27 |
Green Cross Corp:The |
パーフルオロカーボン化合物含有乳化製剤
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5190521A
(en)
|
1990-08-22 |
1993-03-02 |
Tecnol Medical Products, Inc. |
Apparatus and method for raising a skin wheal and anesthetizing skin
|
|
US5527288A
(en)
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
|
CA2059692C
(en)
|
1991-01-28 |
2004-11-16 |
Peter J. Kniskern |
Pneumoccoccal polysaccharide conjugate vaccine
|
|
GB9118204D0
(en)
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
|
SE9102652D0
(sv)
|
1991-09-13 |
1991-09-13 |
Kabi Pharmacia Ab |
Injection needle arrangement
|
|
US5371197A
(en)
|
1991-09-24 |
1994-12-06 |
Merck & Co., Inc. |
Protein-dimeric polysaccharide conjugate vaccine
|
|
US5328483A
(en)
|
1992-02-27 |
1994-07-12 |
Jacoby Richard M |
Intradermal injection device with medication and needle guard
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5674698A
(en)
|
1992-09-14 |
1997-10-07 |
Sri International |
Up-converting reporters for biological and other assays using laser excitation techniques
|
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
|
US5334144A
(en)
|
1992-10-30 |
1994-08-02 |
Becton, Dickinson And Company |
Single use disposable needleless injector
|
|
US5500161A
(en)
|
1993-09-21 |
1996-03-19 |
Massachusetts Institute Of Technology And Virus Research Institute |
Method for making hydrophobic polymeric microparticles
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
IL112372A
(en)
|
1994-02-07 |
2001-08-26 |
Res Dev Foundation |
Non-viral vector for the delivery of genetic information to cells
|
|
WO1995024176A1
(en)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Ampule filling device
|
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
US5565204A
(en)
|
1994-08-24 |
1996-10-15 |
American Cyanamid Company |
Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
|
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
|
AU712981B2
(en)
|
1995-03-22 |
1999-11-18 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
|
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
|
NZ331164A
(en)
|
1996-02-09 |
2000-02-28 |
Univ Liege |
Vaccines against varicella zoster virus gene 63 product
|
|
SE9600647D0
(sv)
|
1996-02-21 |
1996-02-21 |
Bror Morein |
Ny användning
|
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
|
US6420135B1
(en)
|
1996-10-31 |
2002-07-16 |
Human Genome Sciences, Inc. |
Streptococcus pneumoniae polynucleotides and sequences
|
|
DE69841122D1
(de)
|
1997-03-10 |
2009-10-15 |
Coley Pharm Gmbh |
Verwendung von nicht-methyliertem CpG Dinukleotid in Kombination mit Aluminium als Adjuvantien
|
|
CA2288267A1
(en)
|
1997-04-24 |
1998-10-29 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
US6800744B1
(en)
|
1997-07-02 |
2004-10-05 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
|
|
CA2297374A1
(en)
|
1997-07-21 |
1999-01-28 |
North American Vaccine, Inc. |
Modified immunogenic pneumolysin, compositions and their use as vaccines
|
|
US6287568B1
(en)
|
1997-09-09 |
2001-09-11 |
The Trustees Of Columbia University In The City Of New York |
Methods relating to immunogenic dextran-protein conjugates
|
|
US6562798B1
(en)
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
|
US20040247662A1
(en)
|
1998-06-25 |
2004-12-09 |
Dow Steven W. |
Systemic immune activation method using nucleic acid-lipid complexes
|
|
WO2000006738A2
(en)
*
|
1998-07-27 |
2000-02-10 |
Microbial Technics Limited |
NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE)
|
|
JP2002531055A
(ja)
|
1998-07-27 |
2002-09-24 |
マイクロビアル テクニクス リミティッド |
肺炎連鎖球菌のタンパク質及び核酸分子
|
|
GB9817052D0
(en)
|
1998-08-05 |
1998-09-30 |
Smithkline Beecham Biolog |
Vaccine
|
|
CA2355364C
(en)
|
1998-12-21 |
2014-03-18 |
Medimmune, Inc. |
Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
|
|
SE9900496D0
(sv)
|
1999-02-12 |
1999-02-12 |
Pharmatrix Ab |
Vaccine formulation
|
|
GB9928678D0
(en)
|
1999-12-03 |
2000-02-02 |
Provalis Uk Ltd |
Streptococcus pneumoniae antigens
|
|
US6398774B1
(en)
|
1999-09-29 |
2002-06-04 |
Heska Corporation |
Intranasal delivery system
|
|
US8246945B2
(en)
|
2000-04-06 |
2012-08-21 |
University Of Arkansas |
Methods and reagents for decreasing clinical reaction to allergy
|
|
US20020051794A1
(en)
|
2000-08-09 |
2002-05-02 |
Alk-Abello A/S |
Novel parenteral vaccine formulations and uses thereof
|
|
JP2004509970A
(ja)
|
2000-09-26 |
2004-04-02 |
ハイブリドン・インコーポレイテッド |
位置的化学変化による免疫刺激オリゴヌクレオチドアナログの免疫刺激活性の調節
|
|
SE0003538D0
(sv)
|
2000-09-29 |
2000-09-29 |
Isconova Ab |
New immunogenic complex
|
|
GB0107658D0
(en)
*
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
|
EP1450856B1
(en)
|
2001-09-14 |
2009-11-11 |
Cytos Biotechnology AG |
Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use
|
|
JP4360906B2
(ja)
|
2001-09-14 |
2009-11-11 |
サイトス バイオテクノロジー アーゲー |
ウィルス様粒子によって誘導される免疫応答を高めるための、抗原提示細胞のインビボでの活性化
|
|
WO2003044185A2
(en)
|
2001-11-21 |
2003-05-30 |
Affinium Pharmaceuticals, Inc. |
Purified polypeptides involved in general metabolism
|
|
EP1506007B1
(en)
|
2002-05-14 |
2011-06-22 |
Novartis Vaccines and Diagnostics S.r.l. |
Mucosal combination vaccines for bacterial meningitis
|
|
SE0202110D0
(sv)
|
2002-07-05 |
2002-07-05 |
Isconova Ab |
Iscom preparation and use thereof
|
|
US20060121058A1
(en)
|
2002-08-08 |
2006-06-08 |
Children's Medical Center Corporation |
Anti-pneumococcal preparations
|
|
EP1558280B1
(en)
|
2002-11-07 |
2014-01-08 |
Synergy America, Inc. |
Compositions and methods for treating or preventing pneumococcal infection
|
|
AU2002952548A0
(en)
|
2002-11-08 |
2002-11-21 |
Cellestis Limited |
Diagnostic assay
|
|
CA2519511A1
(en)
|
2003-03-17 |
2004-09-30 |
Wyeth Holdings Corporation |
Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
|
|
EP2311988A1
(en)
|
2003-04-15 |
2011-04-20 |
Intercell AG |
S. pneumoniae antigens
|
|
AU2004255526A1
(en)
|
2003-05-07 |
2005-01-20 |
Aventis Pasteur, Inc. |
Method of enhanced immunogenicity to meningococcal vaccination
|
|
SE0301998D0
(sv)
|
2003-07-07 |
2003-07-07 |
Isconova Ab |
Quil A fraction with low toxicity and use thereof
|
|
US20050013812A1
(en)
|
2003-07-14 |
2005-01-20 |
Dow Steven W. |
Vaccines using pattern recognition receptor-ligand:lipid complexes
|
|
GB0318688D0
(en)
|
2003-08-08 |
2003-09-10 |
Chiron Srl |
Streptococcus pneumoniae knockout mutants
|
|
JP5097400B2
(ja)
|
2003-09-03 |
2012-12-12 |
デンドリセラピューティクス、インク． |
複合ワクチン
|
|
US7611712B2
(en)
|
2003-10-23 |
2009-11-03 |
Nelson M. Karp |
Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide
|
|
US20050181035A1
(en)
|
2004-02-17 |
2005-08-18 |
Dow Steven W. |
Systemic immune activation method using non CpG nucleic acids
|
|
US20050226899A1
(en)
|
2004-04-08 |
2005-10-13 |
Mauro Castiglioni |
Cosmetic mask composition
|
|
WO2005103073A2
(en)
|
2004-04-27 |
2005-11-03 |
Intercell Ag |
Td antigens
|
|
GB0410220D0
(en)
|
2004-05-07 |
2004-06-09 |
Kirkham Lea Ann |
Mutant pneumolysin proteins
|
|
JP2008509682A
(ja)
|
2004-08-18 |
2008-04-03 |
ガヴァナーズ オブ ザ ユニヴァーシティー オブ アルバータ |
Ｙｅｂｆを利用するタンパク質の製造方法
|
|
FI20041396A0
(fi)
|
2004-10-29 |
2004-10-29 |
Vesa Pekka Hytoenen |
Uudet mikrobiavidiinit
|
|
GB0428394D0
(en)
|
2004-12-24 |
2005-02-02 |
Chiron Srl |
Saccharide conjugate vaccines
|
|
WO2006078213A1
(en)
|
2005-01-20 |
2006-07-27 |
Isconova Ab |
Vaccine composition comprisinga fibronectin binding protein or a fibronectin binding peptide
|
|
US20090202528A1
(en)
|
2005-02-11 |
2009-08-13 |
Thomas Kofoed |
Surface-Located Streptococcus Pneumoniae Polypeptides
|
|
US20090148894A1
(en)
|
2005-08-15 |
2009-06-11 |
Broedel Sheldon E |
Methods for optimizing the secretion of protein in prokaryotes
|
|
EP1967204B1
(en)
|
2005-09-01 |
2013-10-30 |
Novartis Vaccines and Diagnostics GmbH |
Multiple vaccination including serogroup c meningococcus
|
|
CA2632663C
(en)
|
2005-12-08 |
2015-08-18 |
University Of Louisville Research Foundation, Inc. |
Immunostimulatory compositions and methods
|
|
WO2007081583A2
(en)
|
2006-01-04 |
2007-07-19 |
Children's Medical Center Corporation |
Anti-pneumococcal preparations and methods of use
|
|
US7943133B2
(en)
|
2006-02-02 |
2011-05-17 |
Boston Biocom Llc |
Mesothelin antibody protein fusions and methods of use
|
|
EP1988918A4
(en)
|
2006-02-22 |
2010-04-28 |
Novavax Inc |
ADJUVANZ AND VACCINE COMPOSITIONS
|
|
US20080032340A1
(en)
|
2006-06-09 |
2008-02-07 |
University Of Arizona |
Peptide motifs for binding avidin or neutravidin
|
|
US8148084B2
(en)
|
2006-06-22 |
2012-04-03 |
Dana-Farber Cancer Institute, Inc. |
Diagnosis of autoimmune disease
|
|
WO2007150020A1
(en)
|
2006-06-23 |
2007-12-27 |
Simon Paul M |
Targeted immune conjugates
|
|
US7452985B2
(en)
|
2006-08-17 |
2008-11-18 |
Visgeneer, Inc. |
Human Ron-related gene variant associated with cancers
|
|
ES2517869T3
(es)
|
2006-09-12 |
2014-11-04 |
Alphavax, Inc. |
Partículas de replicones de alfavirus emparejadas con antígenos proteicos como adyuvantes inmunológicos
|
|
AU2007342333B2
(en)
|
2006-09-12 |
2013-02-28 |
Alphavax, Inc. |
Alphavirus replicon particles encoding IL- 12 as immunological adjuvants
|
|
AU2007317347B2
(en)
|
2006-11-03 |
2014-02-06 |
Alphavax, Inc. |
Alphavirus and alphavirus replicon particle formulations and methods
|
|
WO2008061243A2
(en)
|
2006-11-16 |
2008-05-22 |
Novavax, Inc. |
Respiratory syncytial virus-virus like particle (vlps)
|
|
WO2008152448A2
(en)
|
2006-12-21 |
2008-12-18 |
Emergent Product Development Uk Limited |
Streptococcus proteins, and their use in vaccination
|
|
CN100579152C
(zh)
|
2007-01-29 |
2010-01-06 |
华为技术有限公司 |
一种播放集团彩铃的方法、系统及装置
|
|
EP2108047B1
(en)
|
2007-01-31 |
2012-10-24 |
Pfenex Inc. |
Bacterial leader sequences for increased expression
|
|
WO2008119358A2
(en)
|
2007-03-30 |
2008-10-09 |
Ace Biosciences A/S |
Surface-located streptococcus pneumoniae polypeptides for use in vaccine compositions
|
|
CA2683748C
(en)
|
2007-04-13 |
2016-02-16 |
The Board Of Regents Of The University Of Oklahoma |
Mutants of cholesterol-dependent cytolysins and uses thereof
|
|
WO2009000824A2
(en)
|
2007-06-26 |
2008-12-31 |
Glaxosmithkline Biologicals S.A. |
Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
|
|
GB0714963D0
(en)
*
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
|
EP2176291A1
(en)
|
2007-08-10 |
2010-04-21 |
Wacker Chemie AG |
Expression of full length igg and secretion into the culture medium of prokaryotic cells
|
|
KR101661946B1
(ko)
|
2007-08-31 |
2016-10-05 |
유니버시티 오브 시카고 |
스타필로코커스 폐 질환 및 상태에 대한 면역화와 관련된 방법 및 조성물
|
|
US20090068288A1
(en)
|
2007-09-07 |
2009-03-12 |
Wayne Kruger |
Topical antiseptic veterinary solution
|
|
US9125863B2
(en)
|
2008-05-22 |
2015-09-08 |
Children's Medical Center Corporation |
Synergistic immunogenic fusion protein-polysaccharide conjugate
|
|
EP2379106A4
(en)
|
2008-12-17 |
2012-06-13 |
Genocea Biosciences Inc |
ANTIGENS OF CHLAMYDIAS AND USES THEREOF
|
|
AU2009329782B2
(en)
|
2008-12-24 |
2016-01-28 |
The Kingdom Of The Netherlands, Represented By The Minister Of Health, Welfare And Sport, On Behalf Of The Minister, The National Institute Of Public Health And The Environment |
Modified Streptococcus pneumonia pneumolysin (PLY) polypeptides
|
|
EP2208787A1
(en)
|
2009-01-19 |
2010-07-21 |
Université de Liège |
A recombinant alpha-hemolysin polypeptide of Staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted
|
|
US8828953B2
(en)
|
2009-04-20 |
2014-09-09 |
NaZura BioHealth, Inc. |
Chemosensory receptor ligand-based therapies
|
|
ES2732815T3
(es)
|
2009-05-22 |
2019-11-26 |
Genocea Biosciences Inc |
Vacunas frente al virus del herpes simple de tipo 2: composiciones y métodos para provocar una respuesta inmunitaria
|
|
SG177402A1
(en)
|
2009-06-29 |
2012-02-28 |
Genocea Biosciences Inc |
Vaccines and compositions against streptococcus pneumoniae
|
|
US9827299B2
(en)
|
2009-10-09 |
2017-11-28 |
Children's Medical Center Corporation |
Selectively disrupted whole-cell vaccine
|
|
EP2335721A1
(en)
|
2009-12-21 |
2011-06-22 |
Institut Pasteur |
Streptavidin and Biotin-based antigen delivery system
|
|
US20110159040A1
(en)
|
2009-12-30 |
2011-06-30 |
Children's Medical Center Corporation |
Novel immunogens and methods for discovery and screening thereof
|
|
US20130115230A1
(en)
|
2010-04-30 |
2013-05-09 |
Augmenta Biologicals, Llc |
Delivery proteins
|
|
AU2011316924A1
(en)
|
2010-10-20 |
2013-05-02 |
Genocea Biosciences, Inc. |
Chlamydia antigens and uses thereof
|
|
WO2012100233A1
(en)
|
2011-01-20 |
2012-07-26 |
Genocea Biosciences, Inc. |
Vaccines and compositions against streptococcus pneumoniae
|
|
EP2706991B1
(en)
|
2011-05-11 |
2021-03-24 |
Children's Medical Center Corporation |
Multiple antigen presenting immunogenic composition, and methods and uses thereof
|
|
US9765125B2
(en)
|
2012-01-20 |
2017-09-19 |
Genocea Biosciences, Inc. |
Fused antigen vaccines and compositions against Streptococcus pneumoniae
|
|
WO2014018904A1
(en)
|
2012-07-26 |
2014-01-30 |
Genocea Biosciences, Inc. |
Fused antigen vaccines and compositions against streptococcus pneumoniae
|
|
US11576958B2
(en)
|
2013-02-07 |
2023-02-14 |
Children's Medical Center Corporation |
Protein antigens that provide protection against pneumococcal colonization and/or disease
|
|
TWI720448B
(zh)
|
2015-07-21 |
2021-03-01 |
美商輝瑞股份有限公司 |
包含經共軛之莢膜糖抗原的致免疫性組成物、包含該致免疫性組成物之套組及彼等之用途
|
|
PE20211112A1
(es)
|
2018-09-12 |
2021-06-22 |
Affinivax Inc |
Vacunas neumococicas multivalentes
|
|
TWI852943B
(zh)
|
2018-09-12 |
2024-08-21 |
美商兒童醫療中心公司 |
肺炎鏈球菌融合蛋白疫苗
|